−108
Axsome Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−117
FY23:
−145
FY24:
−128
FY25:
−93.4
Change from FY21 to FY25
millions USD
FY21:
−0.31
FY22:
−53.7
FY23:
−0.58
FY24:
−0.27
FY25:
−0.48
Change from FY21 to FY25
millions USD
FY21:
11.1
FY22:
285
FY23:
331
FY24:
57.8
FY25:
101
millions USD
FY21:
−97.4
FY22:
114
FY23:
185
FY24:
−70.8
FY25:
7.58
(positive)
Change from FY21 to FY25
millions USD
FY21:
−109
FY22:
−117
FY23:
−146
FY24:
−129
FY25:
−93.9
All amounts in millions USD